Two children died from gene therapies in China: where the field goes next

TL;DR - Nature reports that two children died following gene therapies in China, raising concerns about safety oversight and transparency. Strengthened disclosure laws could improve reporting of future deaths, but the incidents risk damaging China’s standing in gene-therapy research.

• The provided excerpt does not identify the therapies, conditions treated, or causes of death.
• The article emphasizes the need for rapid public disclosure of serious adverse events.
• Regulatory reforms may strengthen transparency, but their implementation will shape confidence in the field.